NCT03005067 - To Evaluate the Efficacy and Safety of 1146A Nasal Spray in Adult Participants With Symptoms of Common Cold | Biotech Hunter

Enrollment

171

Participants

Timeline

Start Date

December 29, 2016

Primary Completion Date

June 7, 2017

Study Completion Date

June 7, 2017

Conditions

Common Cold

Interventions

DRUG

Carbomer 980 (1146A)

Test product containing carbomer 980 gel

OTHER

Placebo

Reference product containing vehicle without carbomer 980 gel

Trial Locations (24)

19040

GSK Investigational Site, Hatboro

29621

GSK Investigational Site, Anderson

33781

GSK Investigational Site, Pinellas Park

35211

GSK Investigational Site, Birmingham

44311

GSK Investigational Site, Akron

45249

GSK Investigational Site, Cincinnati

51503

GSK Investigational Site, Council Bluffs

55435

GSK Investigational Site, Edina

60602

GSK Investigational Site, Chicago

63141

GSK Investigational Site, St Louis

68022

GSK Investigational Site, Elkhorn

68025

GSK Investigational Site, Fremont

68144

GSK Investigational Site, Omaha

75093

GSK Investigational Site, Plano

75234

GSK Investigational Site, Dallas

78229

GSK Investigational Site, San Antonio

80112

GSK Investigational Site, Centennial

80128

GSK Investigational Site, Littleton

84123

GSK Investigational Site, Murray

85206

GSK Investigational Site, Mesa

85224

GSK Investigational Site, Chandler

92083

GSK Investigational Site, Vista

98004

GSK Investigational Site, Bellevue

Unknown

GSK Investigational Site, Vineland